Clinical trial
Single Arm on the Tolerability of Weekly Nab-paclitaxel
NCT01702844
Study timeline
Study start (actual)2013-06-25Date precision: day
Registry last updated2020-10-08
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Non Small Cell Lung Cancer (NSCLC)unresolved
Interventions
Nab-PaclitaxelDRUG
Sponsors & collaborators
UNC Lineberger Comprehensive Cancer Centerlead sponsor
Celgenecollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01702844 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.